Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial

Bradley A. McGregor, Peter H. O’Donnell, Arjun Vasant Balar, Daniel P. Petrylak, Jonathan E. Rosenberg, Evan Y. Yu, David I. Quinn, Elisabeth I. Heath, Mary S. Campbell, Zsolt Hepp, Caroline McKay, Joyce Steinberg, Antoine Regnault, Flora Mazerolle, Matthew D. Galsky